Literature DB >> 20871624

Enhanced pressor response to acute Ang II infusion in mice lacking membrane-associated prostaglandin E2 synthase-1.

Dong-juan Zhang1, Li-hong Chen, Ya-hua Zhang, Guang-rui Yang, Dou Dou, Yuan-sheng Gao, Xiao-yan Zhang, Xiao-mu Kong, Pan Zhao, Dan Pu, Ming-fen Wei, Matthew-D Breyer, You-fei Guan.   

Abstract

AIM: To examine the contribution of vascular membrane-associated prostaglandin E2 synthase-1 (mPGES-1) to acute blood pressure homeostasis.
METHODS: Angiotensin II (AngII, 75 pmol·kg⁻¹·min⁻¹) was continuously infused via the jugular vein into wild-type and mPGES-1(-/-) mice for 30 min, and blood pressure was measured by carotid arterial catheterization. RT-PCR and immunohistochemistry were performed to detect the expression and localization of mPGES-1 in the mouse arterial vessels. Mesenteric arteries were dissected from mice of both genotypes to study vessel tension and measure vascular PGE2 levels.
RESULTS: Wild-type and mPGES-1(-/-) mice showed similar blood pressure levels at baseline, and the acute intravenous infusion of AngII caused a greater increase in mean arterial pressure in the mPGES-1(-/-) group, with a similar diuretic and natriuretic response in both groups. mPGES-1 was constitutively expressed in the aortic and mesenteric arteries and vascular smooth muscle cells of wild-type mice. Strong staining was detected in the smooth muscle layer of arterial vessels. Ex vivo treatment of mesenteric arteries with AngII produced more vasodilatory PGE2 in wild-type than in mPGES-1(-/-) mice. In vitro tension assays further revealed that the mesenteric arteries of mPGES-1(-/-) mice exhibited a greater vasopressor response to AngII than those arteries of wild-type mice.
CONCLUSION: Vascular mPGES-1 acts as an important tonic vasodilator, contributing to acute blood pressure regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20871624      PMCID: PMC3895497          DOI: 10.1038/aps.2010.99

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  55 in total

1.  Expression of prostaglandin E synthase in Barrett's cancer.

Authors:  B H A von Rahden; H J Stein; S A Hartl; J Theisen; B Stigler; J R Siewert; M Sarbia
Journal:  Dis Esophagus       Date:  2008       Impact factor: 3.429

2.  Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.

Authors:  Youfei Guan; Yahua Zhang; Jing Wu; Zhonghua Qi; Guangrui Yang; Dou Dou; Yuansheng Gao; Lihong Chen; Xiaoyan Zhang; Linda S Davis; Mingfeng Wei; Xuefeng Fan; Monica Carmosino; Chuanming Hao; John D Imig; Richard M Breyer; Matthew D Breyer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 3.  Membrane prostaglandin E synthase-1: a novel therapeutic target.

Authors:  Bengt Samuelsson; Ralf Morgenstern; Per-Johan Jakobsson
Journal:  Pharmacol Rev       Date:  2007-09       Impact factor: 25.468

Review 4.  Physiological regulation of prostaglandins in the kidney.

Authors:  Chuan-Ming Hao; Matthew D Breyer
Journal:  Annu Rev Physiol       Date:  2008       Impact factor: 19.318

Review 5.  Microsomal prostaglandin E synthase-1 and blood pressure regulation.

Authors:  T Yang
Journal:  Kidney Int       Date:  2007-05-09       Impact factor: 10.612

6.  Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species.

Authors:  Edgar A Jaimes; Ming-Sheng Zhou; Damien D Pearse; Leopold Puzis; Leopoldo Raij
Journal:  Am J Physiol Renal Physiol       Date:  2007-12-19

Review 7.  Physiologic and pathophysiologic roles of lipid mediators in the kidney.

Authors:  C-M Hao; M D Breyer
Journal:  Kidney Int       Date:  2007-03-14       Impact factor: 10.612

8.  Role of microsomal prostaglandin E synthase 1 in the kidney.

Authors:  Helene Francois; Carie Facemire; Anil Kumar; Laurent Audoly; Beverly Koller; Thomas Coffman
Journal:  J Am Soc Nephrol       Date:  2007-04-18       Impact factor: 10.121

9.  Prostaglandin E2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase.

Authors:  Ana-Marija Hristovska; Lasse E Rasmussen; Pernille B L Hansen; Susan S Nielsen; Rolf M Nüsing; Shuh Narumiya; Paul Vanhoutte; Ole Skøtt; Boye L Jensen
Journal:  Hypertension       Date:  2007-07-16       Impact factor: 10.190

10.  Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress.

Authors:  Carly LaCroix; Jessica Freeling; Alese Giles; Jürgen Wess; Yi-Fan Li
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-11-30       Impact factor: 4.733

View more
  10 in total

1.  Frontiers of vascular biology and disease research.

Authors:  Alex F Chen; Chao-shu Tang
Journal:  Acta Pharmacol Sin       Date:  2010-10       Impact factor: 6.150

2.  Targeting microsomal prostaglandin E synthase 1 to develop drugs treating the inflammatory diseases.

Authors:  Qian Wang; Yuanyuan Li; Mengying Wu; Songming Huang; Aihua Zhang; Yue Zhang; Zhanjun Jia
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

Review 3.  Prostaglandin E2 modulation of blood pressure homeostasis: studies in rodent models.

Authors:  Christina E Swan; Richard M Breyer
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-07-27       Impact factor: 3.072

4.  Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion.

Authors:  Pamela Harding; Xiao-Ping Yang; Quan He; Margot C Lapointe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-30       Impact factor: 4.733

5.  Cell selective cardiovascular biology of microsomal prostaglandin E synthase-1.

Authors:  Lihong Chen; Guangrui Yang; Xiufeng Xu; Gregory Grant; John A Lawson; Mohammad Bohlooly-Y; Garret A FitzGerald
Journal:  Circulation       Date:  2012-11-30       Impact factor: 29.690

Review 6.  Regulation and function of renal medullary cyclooxygenase-2 during high salt loading.

Authors:  Tianxin Yang; Mi Liu
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

7.  Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and Mice.

Authors:  Yuling Chi; Jean-Francois Jasmin; Yoshinori Seki; Michael P Lisanti; Maureen J Charron; David J Lefer; Victor L Schuster
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

Review 8.  Role of COX-2/mPGES-1/prostaglandin E2 cascade in kidney injury.

Authors:  Zhanjun Jia; Yue Zhang; Guixia Ding; Kristina Marie Heiney; Songming Huang; Aihua Zhang
Journal:  Mediators Inflamm       Date:  2015-02-01       Impact factor: 4.711

Review 9.  An Update of Microsomal Prostaglandin E Synthase-1 and PGE2 Receptors in Cardiovascular Health and Diseases.

Authors:  Guangrui Yang; Lihong Chen
Journal:  Oxid Med Cell Longev       Date:  2016-08-09       Impact factor: 6.543

10.  The Prostaglandin E2 Receptor EP4 Promotes Vascular Neointimal Hyperplasia through Translational Control of Tenascin C via the cAPM/PKA/mTORC1/rpS6 Pathway.

Authors:  Hu Xu; Bingying Fang; Chengzhen Bao; Xiuhui Mao; Chunhua Zhu; Lan Ye; Qian Liu; Yaqing Li; Chunxiu Du; Hang Qi; Xiaoyan Zhang; Youfei Guan
Journal:  Cells       Date:  2022-08-31       Impact factor: 7.666

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.